Andere Kunden interessierten sich auch für
![The Pharmagellan Guide to Biotech Forecasting and Valuation]( "The Pharmagellan Guide to Biotech Forecasting and Valuation")
The Pharmagellan Guide to Biotech Forecasting and Valuation98,99 €![Statistical Issues in the Design and Analysis of Clinical Trials]( "Statistical Issues in the Design and Analysis of Clinical Trials")
Statistical Issues in the Design and Analysis of Clinical Trials58,99 €![The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them]( "The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them")
The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them12,99 €![Building Biotechnology]( "Building Biotechnology")
Building Biotechnology53,99 €![Building Biotechnology]( "Building Biotechnology")
Building Biotechnology60,99 €![Social responsibility drives pharma growth]( "Social responsibility drives pharma growth")
Social responsibility drives pharma growth24,99 €![Diverse Perspectives and State-of-the-Art Approaches to the Utilization of Data-Driven Clinical Decision Support Systems]( "Diverse Perspectives and State-of-the-Art Approaches to the Utilization of Data-Driven Clinical Decision Support Systems")
Diverse Perspectives and State-of-the-Art Approaches to the Utilization of Data-Driven Clinical Decision Support Systems362,99 €
If you work in or around biotech, you're supposed to understand clinical trial results. But what if you're not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation. The Pharmagellan Guide to Analyzing Biotech Clinical Trials is a comprehensive primer to help non-experts evaluate clinical studies of new therapies.Structured roadmap for assessing the main components of a planned or completed biotech trial. Clear explanations of the most common concepts and terms in biotech clinical studies, illustrated with over 100 real-world examples. Deep dives on essential topics like p values, sample size calculations, and Kaplan-Meier curves, written in plain English for non-statisticians. Pointers for interpreting positive and negative study results, understanding common figures and tables, and identifying red flags in press releases. If you're a biotech executive, investor, advisor, or entrepreneur - or aspire to be one - this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence.